Extensive somatic L1 retrotransposition in colorectal tumors

Genome Research

Volumn 22, Issue 12, 2012, Pages 2328-2338

  Solyom, Szilvia ^a   Ewing, Adam D ^b   Rahrmann, Eric P ^c   Doucet, Tara ^a   Nelson, Heather H ^c   Burns, Michael B ^c   Harris, Reuben S ^c   Sigmon, David F ^a   Casella, Alex ^a   Erlanger, Bracha ^a   Wheelan, Sarah ^a   Upton, Kyle R ^d   Shukla, Ruchi ^e   Faulkner, Geoffrey J ^d,e,f   Largaespada, David A ^c   Kazazian, Haig H ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of California Santa Cruz   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d MATER MEDICAL RESEARCH INSTITUTE   (Australia)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADOLESCENT; AGED; ARTICLE; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DNA POLYMORPHISM; GENE INSERTION; GENE SEQUENCE; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN TISSUE; MALE; MUTAGENESIS; PRIORITY JOURNAL; RETROPOSON; VALIDATION PROCESS;

EID: 84870482898     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.145235.112     Document Type: Article

References (63)

1. Asch HL, Eliacin E, Fanning TG, Connolly JL, Bratthauer G, Asch BB. 1996. Comparative expression of the LINE-1 p40 protein in human breast carcinomas and normal breast tissues. Oncol Res 8: 239-247. (Pubitemid 26357607)
2. Ashktorab H, Smoot DT, Carethers JM, Rahmanian M, Kittles R, Vosganian G, Doura M, Nidhiry E, Naab T, Momen B, et al. 2003. High incidence of microsatellite instability in colorectal cancer from African Americans. Clin Cancer Res 9: 1112-1117. (Pubitemid 36323719)
3. Babushok DV, Ostertag EM, Courtney CE, Choi JM, Kazazian HH Jr. 2006. L1 integration in a transgenic mouse model. Genome Res 16: 240-250. (Pubitemid 43200273)
4. Baillie JK, Barnett MW, Upton KR, Gerhardt DJ, Richmond TA, De Sapio F, Brennan PM, Rizzu P, Smith S, Fell M, et al. 2011. Somatic retrotransposition alters the genetic landscape of the human brain. Nature 479: 534-537.
5. Beck CR, Collier P, Macfarlane C, Malig M, Kidd JM, Eichler EE, Badge RM, Moran JV. 2010. LINE-1 retrotransposition activity in human genomes. Cell 141: 1159-1170.
6. Beck CR, Garcia-Perez JL, Badge RM, Moran JV. 2011. LINE-1 elements in structural variation and disease. Annu Rev Genomics Hum Genet 12: 187-215.
7. Bogerd HP, Wiegand HL, Hulme AE, Garcia-Perez JL, O'Shea KS, Moran JV, Cullen BR. 2006. Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. Proc Natl Acad Sci 103: 8780-8785. (Pubitemid 43878096)
8. Boissinot S, Chevret P, Furano AV. 2000. L1 (LINE-1) retrotransposon evolution and amplification in recent human history. Mol Biol Evol 17: 915-928. (Pubitemid 30346551)
9. Bourc'his D, Bestor TH. 2004. Meiotic catastrophe and retrotransposon reactivation in male germ cells lacking Dnmt3L. Nature 431: 96-99. (Pubitemid 39215115)
10. Bratthauer GL, Fanning TG. 1992. Active LINE-1 retrotransposons in human testicular cancer. Oncogene 7: 507-510.
11. Brouha B, Schustak J, Badge RM, Lutz-Prigge S, Farley AH, Moran JV, Kazazian HH Jr. 2003. Hot L1s account for the bulk of retrotransposition in the human population. Proc Natl Acad Sci 100: 5280-5285. (Pubitemid 36542696)
12. Chen H, Lilley CE, Yu Q, Lee DV, Chou J, Narvaiza I, Landau NR, Weitzman MD. 2006. APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons. Curr Biol 16: 480-485. (Pubitemid 43343708)
13. Cost GJ, Feng Q, Jacquier A, Boeke JD. 2002. Human L1 element target-primed reverse transcription in vitro. EMBO J 21: 5899-5910. (Pubitemid 35315287)
14. Coufal NG, Garcia-Perez JL, Peng GE, Marchetto MC, Muotri AR, Mu Y, Carson CT, Macia A, Moran JV, Gage FH. 2011. Ataxia telangiectasia mutated (ATM) modulates long interspersed element-1 (L1) retrotransposition in human neural stem cells. Proc Natl Acad Sci 108: 20382-20387.
15. de Koning AP, Gu W, Castoe TA, Batzer MA, Pollock DD. 2011. Repetitive elements may comprise over two-thirds of the human genome. PLoS Genet 7: e1002384. doi: 10.1371/journal.pgen.1002384.
16. Dewannieux M, Esnault C, Heidmann T. 2003. LINE-mediated retrotransposition of marked Alu sequences. Nat Genet 35: 41-48. (Pubitemid 37048594)
17. Esnault C, Maestre J, Heidmann T. 2000. Human LINE retrotransposons generate processed pseudogenes. Nat Genet 24: 363-367. (Pubitemid 30187433)
18. Ewing AD, Kazazian HH Jr. 2010. High-throughput sequencing reveals extensive variation in human-specific L1 content in individual human genomes. Genome Res 20: 1262-1270.
19. Ewing AD, Kazazian HH Jr. 2011. Whole-genome resequencing allows detection of many rare LINE-1 insertion alleles in humans. Genome Res 21: 985-990.
20. Feng Q, Moran JV, Kazazian HH Jr, Boeke JD. 1996. Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell 87: 905-916. (Pubitemid 26404289)
21. Gasior SL, Wakeman TP, Xu B, Deininger PL. 2006. The human LINE-1 retrotransposon creates DNA double-strand breaks. J Mol Biol 357: 1383-1393.
22. Gilbert N, Lutz S, Morrish TA, Moran JV. 2005. Multiple fates of L1 retrotransposition intermediates in cultured human cells. Mol Cell Biol 25: 7780-7795. (Pubitemid 41170138)
23. Goodier JL, Kazazian HH Jr. 2008. Retrotransposons revisited: The restraint and rehabilitation of parasites. Cell 135: 23-35.
24. Goodier JL, Ostertag EM, Kazazian HH Jr. 2000. Transduction of 39-flanking sequences is common in L1 retrotransposition. Hum Mol Genet 9: 653-657. (Pubitemid 30154024)
25. Hancks DC, Kazazian HH. 2012. Active human retrotransposons: Variation and disease. Curr Opin Genet Dev 22: 191-203.
26. Hancks DC, Goodier JL, Mandal PK, Cheung LE, Kazazian HH Jr. 2011. Retrotransposition of marked SVA elements by human L1s in cultured cells. Hum Mol Genet 20: 3386-3400.
27. Harris CR, Normart R, Yang Q, Stevenson E, Haffty BG, Ganesan S, Cordon-Cardo C, Levine AJ, Tang LH. 2010. Association of nuclear localization of a long interspersed nuclear element-1 protein in breast tumors with poor prognostic outcomes. Genes Cancer. 1: 115-124.
28. Holmes SE, Dombroski BA, Krebs CM, Boehm CD, Kazazian HH Jr. 1994. A new retrotransposable human L1 element from the LRE2 locus on chromosome 1q produces a chimaeric insertion. Nat Genet 7: 143-148. (Pubitemid 24174651)
29. Hormozdiari F, Alkan C, Ventura M, Hajirasouliha I, Malig M, Hach F, Yorukoglu D, Dao P, Bakhshi M, Sahinalp SC, et al. 2011. Alu repeat discovery and characterization within human genomes. Genome Res 21: 840-849.
30. Hsu F, Kent WJ, Clawson H, Kuhn RM, Diekhans M, Haussler D. 2006. The UCSC known genes. Bioinformatics 22: 1036-1046.
31. Huang CR, Schneider AM, Lu Y, Niranjan T, Shen P, Robinson MA, Steranka JP, Valle D, Civin CI, Wang T, et al. 2010. Mobile interspersed repeats are major structural variants in the human genome. Cell 141: 1171-1182.
32. Iskow RC, McCabe MT, Mills RE, Torene S, Pittard WS, Neuwald AF, Van Meir EG, Vertino PM, Devine SE. 2010. Natural mutagenesis of human genomes by endogenous retrotransposons. Cell 141: 1253-1261.
33. Kaneko H, Dridi S, Tarallo V, Gelfand BD, Fowler BJ, Cho WG, Kleinman ME, Ponicsan SL, Hauswirth WW, Chiodo VA, et al. 2011. DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration. Nature 471: 325-330.
34. Kloor M, Sutter C, Wentzensen N, Cremer FW, Buckowitz A, Keller M, von Knebel Doeberitz M, Gebert J. 2004. A large MSH2 Alu insertion mutation causes HNPCC in a German kindred. Hum Genet 115: 432-438. (Pubitemid 39341718)
35. Lee E, Iskow R, Yang L, Gokcumen O, Haseley P, Luquette LJ III, Lohr JG, Harris CC, Ding L, Wilson RK, et al. 2012. Landscape of somatic retrotransposition in human cancers. Science 337: 967-971.
36. Luan DD, Korman MH, Jakubczak JL, Eickbush TH. 1993. Reverse transcription of R2BmRNA is primed by a nick at the chromosomal target site: A mechanism for non-LTR retrotransposition. Cell 72: 595-605. (Pubitemid 23077747)
37. Mathias SL, Scott AF, Kazazian HH Jr, Boeke JD, Gabriel A. 1991. Reverse transcriptase encoded by a human transposable element. Science 254: 1808-1810. (Pubitemid 21917534)
38. Maxwell PH, Burhans WC, Curcio MJ. 2011. Retrotransposition is associated with genome instability during chronological aging. Proc Natl Acad Sci 108: 20376-20381.
39. Miki Y, Nishisho I, Horii A, Miyoshi Y, Utsunomiya J, Kinzler KW, Vogelstein B, Nakamura Y. 1992. Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Res 52: 643-645.
40. Moran JV, Holmes SE, Naas TP, DeBerardinis RJ, Boeke JD, Kazazian HH Jr. 1996. High frequency retrotransposition in cultured mammalian cells. Cell 87: 917-927. (Pubitemid 26404290)
41. Moran JV, DeBerardinis RJ, Kazazian HH Jr. 1999. Exon shuffling by L1 retrotransposition. Science 283: 1530-1534.
42. Morrish TA, Gilbert N, Myers JS, Vincent BJ, Stamato TD, Taccioli GE, Batzer MA, Moran JV. 2002. DNA repair mediated by endonuclease-independent LINE-1 retrotransposition. Nat Genet 31: 159-165.
43. Muckenfuss H, Hamdorf M, Held U, Perkovic M, Lower J, Cichutek K, Flory E, Schumann GG, Munk C. 2006. APOBEC3 proteins inhibit human LINE-1 retrotransposition. J Biol Chem 281: 22161-22172. (Pubitemid 44181920)
44. Muller A, Edmonston TB, Dietmaier W, Buttner R, Fishel R, Ruschoff J. 2004. MSI-testing in hereditary non-polyposis colorectal carcinoma (HNPCC). Dis Markers 20: 225-236. (Pubitemid 40164095)
45. Ohshima K, Hattori M, Yada T, Gojobori T, Sakaki Y, Okada N. 2003. Whole-genome screening indicates a possible burst of formation of processed pseudogenes and Alu repeats by particular L1 subfamilies in ancestral primates. Genome Biol 4: R74. doi: 10.1186/gb-2003-4-11-r74.
46. Oricchio E, Sciamanna I, Beraldi R, Tolstonog GV, Schumann GG, Spadafora C. 2007. Distinct roles for LINE-1 and HERV-K retroelements in cell proliferation, differentiation and tumor progression. Oncogene 26: 4226-4233. (Pubitemid 46975802)
47. Ostertag EM, Goodier JL, Zhang Y, Kazazian HH Jr. 2003. SVA elements are nonautonomous retrotransposons that cause disease in humans. Am J Hum Genet 73: 1444-1451. (Pubitemid 38037435)
48. Pavlicek A, Paces J, Zika R, Hejnar J. 2002. Length distribution of long interspersed nucleotide elements (LINEs) and processed pseudogenes of human endogenous retroviruses: Implications for retrotransposition and pseudogene detection. Gene 300: 189-194. (Pubitemid 35441174)
49. Pickeral OK, Makalowski W, Boguski MS, Boeke JD. 2000. Frequent human genomic DNA transduction driven by LINE-1 retrotransposition. Genome Res 10: 411-415. (Pubitemid 30259072)
50. Raiz J, Damert A, Chira S, Held U, Klawitter S, Hamdorf M, Lower J, Stratling WH, Lower R, Schumann GG. 2011. The non-autonomous retrotransposon SVA is trans-mobilized by the human LINE-1 protein machinery. Nucleic Acids Res 40: 1666-1683.
51. Solyom S, Ewing AD, Hancks DC, Takeshima Y, Awano H, Matsuo M, Kazazian HH Jr. 2012. Pathogenic orphan transduction created by a nonreference LINE-1 retrotransposon. Hum Mutat 33: 369-371.
52. Stenglein MD, Harris RS. 2006. APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. J Biol Chem 281: 16837-16841.
53. Stewart C, Kural D, Stromberg MP, Walker JA, Konkel MK, Stutz AM, Urban AE, Grubert F, Lam HY, Lee WP, et al. 2011. A comprehensive map of mobile element insertion polymorphisms in humans. PLoS Genet 7: e1002236. doi: 10.1371/journal.pgen.1002236.
54. Su LK, Steinbach G, Sawyer JC, Hindi M, Ward PA, Lynch PM. 2000. Genomic rearrangements of the APC tumor-suppressor gene in familial adenomatous polyposis. Hum Genet 106: 101-107. (Pubitemid 30156401)
55. Su Y, Davies S, Davis M, Lu H, Giller R, Krailo M, Cai Q, Robison L, Shu XO, Children's Oncology Group. 2007. Expression of LINE-1 p40 protein in pediatric malignant germ cell tumors and its association with clinicopathological parameters: A report from the Children's Oncology Group. Cancer Lett 247: 204-212. (Pubitemid 46240607)
56. Suzuki J, Yamaguchi K, Kajikawa M, Ichiyanagi K, Adachi N, Koyama H, Takeda S, Okada N. 2009. Genetic evidence that the non-homologous end-joining repair pathway is involved in LINE retrotransposition. PLoS Genet 5: e1000461. doi: 10.1371/journal.gen.1000461.
57. van der Klift HM, Tops CM, Hes FJ, Devilee P, Wijnen JT. 2012. Insertion of an SVA element, a nonautonomous retrotransposon, in PMS2 intron 7 as a novel cause of lynch syndrome. Hum Mutat 33: 1051-1055.
58. Wei W, Gilbert N, Ooi SL, Lawler JF, Ostertag EM, Kazazian HH, Boeke JD, Moran JV. 2001. Human L1 retrotransposition: cis preference versus trans complementation. Mol Cell Biol 21: 1429-1439. (Pubitemid 32114989)
59. Wilhelm CS, Kelsey KT, Butler R, Plaza S, Gagne L, Zens MS, Andrew AS, Morris S, Nelson HH, Schned AR, et al. 2010. Implications of LINE1 methylation for bladder cancer risk in women. Clin Cancer Res 16: 1682-1689.
60. Witherspoon DJ, Xing J, Zhang Y, Watkins WS, Batzer MA, Jorde LB. 2010. Mobile element scanning (ME-Scan) by targeted high-throughput sequencing. BMC Genomics 11: 410. doi: 10.1186/1471-2164-11-410.
61. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ, Shen D, Boca SM, Barber T, Ptak J, et al. 2007. The genomic landscapes of human breast and colorectal cancers. Science 318: 1108-1113. (Pubitemid 350134889)
62. Yang N, Zhang L, Zhang Y, Kazazian HH Jr. 2003. An important role for RUNX3 in human L1 transcription and retrotransposition. Nucleic Acids Res 31: 4929-4940. (Pubitemid 37441858)
63. Yoder JA, Walsh CP, Bestor TH. 1997. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet 13: 335-340. (Pubitemid 27309911)